Assess Tolerability, Safety and Pharmacology of hGH-ViaDerm™ System in Adults With GH-Deficiency

Study Title
A Multi-Dose Study to Assess Tolerability, Safety and Pharmacology of hGH-ViaDermג„¢ System in Adults With GH-Deficiency
Teva Identifier
GH-VD-102
ClinicalTrials.gov Identifier
NCT00455260
Study Status
Completed
Trial Condition(s)
Growth Hormone Deficiency
Interventions
Drug: hGH-ViaDermג„¢ System (hGH or somatropin) | Device: hGH-ViaDermג„¢ System

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Click for participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age Range
20 Years to 60 Years
Trial Duration
04/01/2007 - 01/00/1900
Phase
Phase 1

Study Type

Interventional